Pages that link to "Q48836301"
Jump to navigation
Jump to search
The following pages link to The Charing Cross Hospital experience with temozolomide in patients with gliomas (Q48836301):
Displaying 50 items.
- Temozolomide for high grade glioma (Q24197645) (← links)
- Temozolomide for High Grade Glioma (Q24241222) (← links)
- Dexamethasone protected human glioblastoma U87MG cells from temozolomide induced apoptosis by maintaining Bax:Bcl-2 ratio and preventing proteolytic activities (Q24800267) (← links)
- Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse (Q30647642) (← links)
- Phase II study of temozolomide in patients with relapsing high grade glioma and poor performance status (Q31400049) (← links)
- Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies (Q33330748) (← links)
- Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme (Q33346613) (← links)
- Temozolomide in patients with advanced cancer: phase I and pharmacokinetic study (Q33358701) (← links)
- The effect of sequential radiochemotherapy in preirradiated malignant gliomas in a phase II study (Q33360330) (← links)
- Temozolomide for the treatment of recurrent supratentorial glioma: results of a compassionate use program in Belgium (Q33363609) (← links)
- Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group (Q33376286) (← links)
- Multi-institutional phase II study of temozolomide administered twice daily in the treatment of recurrent high-grade gliomas (Q33378539) (← links)
- Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study. (Q33386298) (← links)
- Monitoring pharmacokinetics of anticancer drugs: non-invasive investigation using magnetic resonance spectroscopy (Q33852965) (← links)
- Oral alkylating agents for breast cancer therapy (Q33859915) (← links)
- Chemotherapy for high-grade gliomas (Q33898570) (← links)
- Temozolomide: The evidence for its therapeutic efficacy in malignant astrocytomas (Q33973844) (← links)
- Pharmacotherapy of malignant astrocytomas of children and adults: current strategies and future trends (Q34387557) (← links)
- Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials (Q34429383) (← links)
- A rapid and systematic review of the effectiveness of temozolomide for the treatment of recurrent malignant glioma (Q34547574) (← links)
- Temozolomide. A new option for high-grade astrocytomas (Q34566053) (← links)
- Pharmacokinetic considerations of oral chemotherapy in elderly patients with cancer (Q34585115) (← links)
- MiR-125b acts as an oncogene in glioblastoma cells and inhibits cell apoptosis through p53 and p38MAPK-independent pathways (Q35028282) (← links)
- Pharmacological factors influencing anticancer drug selection in the elderly (Q35182963) (← links)
- Toxicity after radiochemotherapy for glioblastoma using temozolomide--a retrospective evaluation (Q35541071) (← links)
- Temozolomide: realizing the promise and potential (Q35587289) (← links)
- Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report (Q35799962) (← links)
- AKT2-knockdown suppressed viability with enhanced apoptosis, and attenuated chemoresistance to temozolomide of human glioblastoma cells in vitro and in vivo (Q35848478) (← links)
- Complications of a temozolomide overdose: a case report (Q36463078) (← links)
- Drug Insight: temozolomide as a treatment for malignant glioma--impact of a recent trial (Q36577223) (← links)
- A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse (Q36621800) (← links)
- Age, Neurological Status MRC Scale, and Postoperative Morbidity are Prognostic Factors in Patients with Glioblastoma Treated by Chemoradiotherapy. (Q37187292) (← links)
- Temozolomide with radiation therapy in high grade brain gliomas: pharmaceuticals considerations and efficacy; a review article. (Q37454341) (← links)
- Dose-dense temozolomide regimens: antitumor activity, toxicity, and immunomodulatory effects (Q37766550) (← links)
- Systematic review and meta-analysis of temozolomide in animal models of glioma: was clinical efficacy predicted? (Q38074263) (← links)
- Current evidence of temozolomide and bevacizumab in treatment of gliomas. (Q38230650) (← links)
- The role of radiation in treating glioblastoma: here to stay (Q39167423) (← links)
- Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines (Q39874006) (← links)
- Dexamethasone decreases temozolomide-induced apoptosis in human gliobastoma T98G cells. (Q40463014) (← links)
- Survival of human glioma cells treated with various combination of temozolomide and X-rays (Q40875994) (← links)
- Loss of chromosome 10 is an independent prognostic factor in high-grade gliomas (Q41877426) (← links)
- Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases (Q43573415) (← links)
- Temozolomide enhances herpes simplex virus thymidine kinase/ganciclovir therapy of malignant glioma. (Q43761368) (← links)
- Synthesis and antibacterial activity of dual-action agents of a beta-lactam antibiotic with cytotoxic agent mitozolomide or temozolomide (Q43964156) (← links)
- Impact of chromosome 1p status in response of oligodendroglioma to temozolomide: preliminary results (Q44390093) (← links)
- Combined thalidomide and temozolomide treatment in patients with glioblastoma multiforme (Q44835994) (← links)
- Phase II study of concurrent continuous Temozolomide (TMZ) and Tamoxifen (TMX) for recurrent malignant astrocytic gliomas (Q45139628) (← links)
- Brain metastases following interleukin-2 plus interferon-alpha-2a therapy: a follow-up study in 94 stage IV melanoma patients (Q48308116) (← links)
- Malignant glioma: should chemotherapy be overthrown by experimental treatments? (Q48422991) (← links)
- Temozolomide for malignant brain tumours. (Q55475731) (← links)